Google+Linking To And Embedding Dr. Nick Norwitz's "Better Than Statins? The Truth About the New Cholesterol Drug" [The PCSK9 Inhibitor Evolocumab (Repatha) - Tom Wade MD
For the references and more information on other medications, supplements, and what I’m doing, see the newsletter: https://staycuriousmetabolism.substac…
A massive new cardiology study just hit the New England Journal of Medicine — and headlines everywhere claimed that PCSK9 inhibitors like Repatha can reduce heart attack and stroke risk by 25%, even in people who have never had an event before. It sounds like a revolution. It sounds like a breakthrough. But the real story has more nuances.
In this video, we dig into what PCSK9 inhibitors truly do, why LDL and ApoB drop so dramatically and how these drugs compare to statins — including the downsides that rarely make it into mainstream coverage, like increased diabetes risk, mitochondrial damage. We’ll also explore a new emerging compound — a cyclic peptide PCSK9 inhibitor but can be taken by mouth instead of by injection — and I’ll share the experiment I’m running on myself.
• I Tried Statins — Here’s What Happened | D…
